High-resolution ultrasound is the imaging method of choice for the evaluation of thyroid nodules. The method has recently come to be used widely and often, which has increased the rate of thyroid nodule detection. In 2017, the American College of Radiology (ACR) established a risk-stratification system designated the Thyroid Imaging Reporting and Data System (TI-RADS) to be a practical guide for widespread use, with a single lexicon and standardization of ultrasound reports of thyroid nodules. The objective of this study was to present a practical approach, using examples to illustrate the criteria evaluated by the 2017 ACR TI-RADS, in order to help minimize uncertainties regarding its application by sonographers.
High-resolution ultrasound is the imaging method of choice for the evaluation of thyroid nodules. The method has recently come to be used widely and often, which has increased the rate of thyroid nodule detection. In 2017, the American College of Radiology (ACR) established a risk-stratification system designated the Thyroid Imaging Reporting and Data System (TI-RADS) to be a practical guide for widespread use, with a single lexicon and standardization of ultrasound reports of thyroid nodules. The objective of this study was to present a practical approach, using examples to illustrate the criteria evaluated by the 2017 ACR TI-RADS, in order to help minimize uncertainties regarding its application by sonographers.
High-resolution ultrasound is the imaging method of choice for the evaluation of
thyroid nodules. The method has recently come to be used widely and often, which has
increased the rate of thyroid nodule detection. Although the prevalence of thyroid
nodules is high, the incidence of malignancy is relatively low in incidental
nodules([1],[2]).The diagnosis of malignancy depends, above all, on fine-needle aspiration biopsy or
excisional biopsy. To avoid unnecessary procedures, risk stratification through
systematization is essential[(3)]. In
2017, the American College of Radiology (ACR) convened to establish a practical risk
stratification system for widespread use by all medical professionals, resulting in
the Thyroid Imaging Reporting and Data System (TI-RADS), which provides a single
lexicon to reduce confusion in ultrasound reports of thyroid nodules([4],[5],[6]).The objective of this study was to create a practical guide to help minimize
uncertainties regarding the application of the 2017 ACR TI-RADS by sonographers. To
that end, we use examples to illustrate the ACR TI-RADS criteria and scoring.
FEATURES EVALUATED
The ACR TI-RADS is based on the evaluation of five key features of a
nodule—composition, echogenicity, shape, margin, and echogenic foci—which are
scored individually, the feature scores being summed to arrive at the final
classification of the risk level, which ranges from TR1 (benign) to TR5 (highly
suspicious for malignancy). A sixth feature (size) is used in order to determine
the appropriate course of action. For each of the five key features, one of the
options must be chosen and duly scored, with the exception of the “echogenic
foci” feature, in which all the options applicable to the evaluated node must be
described and scored[(4)].
According to the lexicon proposed by the ACR TI-RADS, the features described
above will be designated in categories.
COMPOSITION
The composition of a nodule is defined on the basis of its content (solid tissue
or fluid). That content is classified as detailed below. Cystic –
This describes a nodule that is completely or almost completely filled with
fluid (Figure 1).
Figure 1
Image of a nodule that was completely cystic. Nodules that are
completely cystic, predominantly cystic, or spongiform are not
scored for other categories, therefore automatically receiving a
final score of 0 and classified as TR1.
Image of a nodule that was completely cystic. Nodules that are
completely cystic, predominantly cystic, or spongiform are not
scored for other categories, therefore automatically receiving a
final score of 0 and classified as TR1.Spongiform – This describes a nodule that is composed of multiple
small cystic spaces that occupy at least 50% of the total volume of the
nodule.Mixed solid-cystic – This describes a nodule that combines two
features presented in the original lexicon (predominantly solid and
predominantly cystic)[(4)]. In
the evaluation of these nodules, the characterization of the solid component is
more important than the proportional distribution of the solid and cystic
components (Figure 2).
Figure 2
Image of a mixed solid-cystic nodule. In such nodules, only the solid
component should be scored for the echogenicity, margin, and
echogenic foci categories. In this case, the nodule was assigned 1
point for being mixed, 2 points for being hypoechoic, 0 points for
being wider-than-tall, 0 points for having undefined margins, and 0
points for having no acoustic shadowing artifacts or echogenic foci.
Therefore, the total score was 3 points and the risk level was
classified as TR3.
Image of a mixed solid-cystic nodule. In such nodules, only the solid
component should be scored for the echogenicity, margin, and
echogenic foci categories. In this case, the nodule was assigned 1
point for being mixed, 2 points for being hypoechoic, 0 points for
being wider-than-tall, 0 points for having undefined margins, and 0
points for having no acoustic shadowing artifacts or echogenic foci.
Therefore, the total score was 3 points and the risk level was
classified as TR3.Solid – This describes a nodule that is completely or almost
completely composed of soft tissue (Figure
3). There is no precise definition of the proportion of solid
component required for a nodule to be classified as solid, which is often a
subjective finding. As a general rule, nodules that are mostly solid and contain
cystic spaces accounting for no more than 5% of their total volume are
classified as solid[(5)]. In some
cases, it can be difficult to distinguish between solid content and
debris/hemorrhagic material. In such cases, the use of color Doppler can help
identify flow within the solid component. If the composition of a nodule cannot
be determined, it should be considered to be solid.
Figure 3
Image of a completely solid nodule, with echogenicity similar to the
rest of the thyroid parenchyma, presenting a hypoechoic halo that
should not be scored for the echogenicity or margin categories. The
features of (scores for) this nodule were as follows: solid (2
points); isoechoic (1 point); wider-than-tall (0 points); smooth
margins (0 points); and no acoustic shadowing artifacts or echogenic
foci (0 points). Therefore, the total score was 3 points and the
risk level was classified as TR3.
Image of a completely solid nodule, with echogenicity similar to the
rest of the thyroid parenchyma, presenting a hypoechoic halo that
should not be scored for the echogenicity or margin categories. The
features of (scores for) this nodule were as follows: solid (2
points); isoechoic (1 point); wider-than-tall (0 points); smooth
margins (0 points); and no acoustic shadowing artifacts or echogenic
foci (0 points). Therefore, the total score was 3 points and the
risk level was classified as TR3.
ECHOGENICITY
The echogenicity of a nodule is graded in relation to the adjacent tissue
(thyroid parenchyma or anterior cervical musculature). Note that, for this
category, only the solid component should be taken into account.Hyperechoic – This describes a nodule with increased echogenicity in
relation to the thyroid parenchyma (Figures
4 and 5).
Figure 4
Image of a hyperechoic nodule. The features of (scores for) this
nodule were as follows: solid (2 points); hyperechoic (1 point);
wider-than-tall (0 points); smooth margins (0 points); and no
acoustic shadowing artifacts or echogenic foci (0 points).
Therefore, the total score was 3 points and the risk level was
classified as TR3.
Figure 5
Image of a hyperechoic nodule. Note the heterogeneous echotexture of
the thyroid parenchyma, especially the presence of nodules with
well-defined margins and echogenicity greater than that of the rest
of the parenchyma. The nodule pictured was solid (2 points),
hyperechoic (1 point), and wider-than-tall (0 points), with smooth
margins (0 points) and without acoustic shadowing artifacts or
echogenic foci (0 points). Therefore, the total score was 3 points
and the risk level was classified as TR3.
Image of a hyperechoic nodule. The features of (scores for) this
nodule were as follows: solid (2 points); hyperechoic (1 point);
wider-than-tall (0 points); smooth margins (0 points); and no
acoustic shadowing artifacts or echogenic foci (0 points).
Therefore, the total score was 3 points and the risk level was
classified as TR3.Image of a hyperechoic nodule. Note the heterogeneous echotexture of
the thyroid parenchyma, especially the presence of nodules with
well-defined margins and echogenicity greater than that of the rest
of the parenchyma. The nodule pictured was solid (2 points),
hyperechoic (1 point), and wider-than-tall (0 points), with smooth
margins (0 points) and without acoustic shadowing artifacts or
echogenic foci (0 points). Therefore, the total score was 3 points
and the risk level was classified as TR3.Isoechoic – This describes a nodule with echogenicity similar to
that of the thyroid parenchyma (Figure 3).
If the echogenicity of a nodule cannot be determined, it should be considered
isoechoic for scoring.Hypoechoic – This describes a nodule with reduced echogenicity in
relation to the thyroid parenchyma (Figures
6 and 7).
Figure 6
Image of a predominantly solid nodule with smooth margins that is
less echogenic than the rest of the thyroid parenchyma. The nodule
pictured was solid (2 points), hypoechoic (2 points), and
wider-than-tall (0 points), with well-defined margins (0 points) and
without acoustic shadowing artifacts or echogenic foci (0 points).
Therefore, the total score was 4 points and the risk level was
classified as TR4.
Figure 7
Image of an oval-shaped nodule with well-defined margins and
echogenicity lower than that of the rest of the thyroid parenchyma.
In this case, the nodule was assigned 2 points for being solid, 2
points for being hypoechoic, 0 points for being wider-than-tall, 2
points for having a lobulated margin, and 0 points for having no
acoustic shadowing artifacts or echogenic foci. Therefore, the total
score was 6 points and the risk level was classified as TR4.
Image of a predominantly solid nodule with smooth margins that is
less echogenic than the rest of the thyroid parenchyma. The nodule
pictured was solid (2 points), hypoechoic (2 points), and
wider-than-tall (0 points), with well-defined margins (0 points) and
without acoustic shadowing artifacts or echogenic foci (0 points).
Therefore, the total score was 4 points and the risk level was
classified as TR4.Image of an oval-shaped nodule with well-defined margins and
echogenicity lower than that of the rest of the thyroid parenchyma.
In this case, the nodule was assigned 2 points for being solid, 2
points for being hypoechoic, 0 points for being wider-than-tall, 2
points for having a lobulated margin, and 0 points for having no
acoustic shadowing artifacts or echogenic foci. Therefore, the total
score was 6 points and the risk level was classified as TR4.Markedly hypoechoic – This describes a nodule with reduced
echogenicity in relation to the anterior cervical musculature (Figure 8). This characteristic is highly
specific for malignancy.
Figure 8
Image of a markedly hypoechoic nodule. Compare the echogenicity of
the nodules with that of the cervical musculature. Attention should
be paid to the ultrasound parameters. The nodule pictured was solid
(2 points), markedly hypoechoic (3 points), and wider-than-tall (0
points), with undefined margins (0 points) and without acoustic
shadowing artifacts or echogenic foci (0 points). Therefore, the
total score was 5 points and the risk level was classified as
TR4.
Image of a markedly hypoechoic nodule. Compare the echogenicity of
the nodules with that of the cervical musculature. Attention should
be paid to the ultrasound parameters. The nodule pictured was solid
(2 points), markedly hypoechoic (3 points), and wider-than-tall (0
points), with undefined margins (0 points) and without acoustic
shadowing artifacts or echogenic foci (0 points). Therefore, the
total score was 5 points and the risk level was classified as
TR4.
SHAPE
In the shape category, only one aspect of a nodule is evaluated for ACR TI-RADS
risk stratification: the relationship between its anteroposterior dimension
(tallness) and its transverse dimension (width) on an axial image. A nodule is
classified as either wider-than-tall or taller-than-wide.Taller-than-wide – When the anteroposterior dimension of a nodule is
greater than its transverse dimension (Figure
9), it is classified as taller-than-wide. Although not very
sensitive, this is a finding that id highly specific for malignant lesions,
especially when found in combination with other aspects suggestive of
malignancy.
Figure 9
Image of a predominantly solid, hypoechoic, taller-than-wide nodule
with well-defined margins. The features of (scores for) this nodule
were as follows: solid (2 points), hypoechoic (2 points),
taller-than-wide (3 points), smooth margins (0 points), and no
acoustic shadowing artifacts or echogenic foci (0 points).
Therefore, the total score was 7 points and the risk level was
classified as TR5.
Image of a predominantly solid, hypoechoic, taller-than-wide nodule
with well-defined margins. The features of (scores for) this nodule
were as follows: solid (2 points), hypoechoic (2 points),
taller-than-wide (3 points), smooth margins (0 points), and no
acoustic shadowing artifacts or echogenic foci (0 points).
Therefore, the total score was 7 points and the risk level was
classified as TR5.
MARGIN
The margin category classifies the interface between a nodule and the adjacent
intrathyroidal or extrathyroidal tissue.Smooth – This describes nodule margins that are well-defined,
curved, and uninterrupted (Figure 3).Irregular or lobulated – This describes nodule margins that are
spiculated and jagged, forming acute angles. Such a nodule may or may not have
well-defined soft tissue protrusions into adjacent tissues (Figures 10 and 11).
Figure 10
Image of a solid nodule with lobulated margins and a rounded
lobulation in its anterior portion. In this case, the nodule was
assigned 2 points for being solid, 2 points for being hypoechoic, 0
points for being wider-than-tall, 2 points for having a lobulated
margin, and 0 points for having no acoustic shadowing artifacts or
echogenic foci. Therefore, the total score was 6 points and the risk
level was classified as TR4.
Figure 11
Image of a solid nodule with irregular margins. Note the
irregularity, with an acute angle at the medial margin of the
nodule. The nodule pictured was solid (2 points), hypoechoic (2
points), and wider-than-tall (0 points), with irregular margins (2
points) and without acoustic shadowing artifacts or echogenic foci
(0 points). Therefore, the total score was 6 points and the risk
level was classified as TR4.
Image of a solid nodule with lobulated margins and a rounded
lobulation in its anterior portion. In this case, the nodule was
assigned 2 points for being solid, 2 points for being hypoechoic, 0
points for being wider-than-tall, 2 points for having a lobulated
margin, and 0 points for having no acoustic shadowing artifacts or
echogenic foci. Therefore, the total score was 6 points and the risk
level was classified as TR4.Image of a solid nodule with irregular margins. Note the
irregularity, with an acute angle at the medial margin of the
nodule. The nodule pictured was solid (2 points), hypoechoic (2
points), and wider-than-tall (0 points), with irregular margins (2
points) and without acoustic shadowing artifacts or echogenic foci
(0 points). Therefore, the total score was 6 points and the risk
level was classified as TR4.Extrathyroidal extension – This describes nodule margins that extend
beyond the limits of the thyroid gland, characterized by clear invasion of
adjacent soft tissues or vascular structures (Figure 12).
Figure 12
Image of a nodule extending beyond the anterior limit of the thyroid.
The nodule pictured was solid (2 points), hypoechoic (2 points), and
wider-than-tall (0 points), with extrathyroidal extension (3 points)
and without posterior attenuation artifacts or echogenic foci (0
points). Therefore, the total score was 7 points and the risk level
was classified as TR5.
Image of a nodule extending beyond the anterior limit of the thyroid.
The nodule pictured was solid (2 points), hypoechoic (2 points), and
wider-than-tall (0 points), with extrathyroidal extension (3 points)
and without posterior attenuation artifacts or echogenic foci (0
points). Therefore, the total score was 7 points and the risk level
was classified as TR5.Poorly defined or undefined – This describes nodule margins that are
difficult to distinguish from the thyroid parenchyma (Figure 13), without irregularities or spicules.
Figure 13
Image of a mixed solid-cystic nodule. Note that the medial margin of
the nodule cannot easily be distinguished from the rest of the
parenchyma. In this case, the nodule was assigned 1 point for being
mixed, 2 points for being hypoechoic, 0 points for being
wider-than-tall, 0 points for having ill-defined margins, and 0
points for having no acoustic shadowing artifacts or echogenic foci.
Therefore, the total score was 3 points and the risk level was
classified as TR3.
Image of a mixed solid-cystic nodule. Note that the medial margin of
the nodule cannot easily be distinguished from the rest of the
parenchyma. In this case, the nodule was assigned 1 point for being
mixed, 2 points for being hypoechoic, 0 points for being
wider-than-tall, 0 points for having ill-defined margins, and 0
points for having no acoustic shadowing artifacts or echogenic foci.
Therefore, the total score was 3 points and the risk level was
classified as TR3.Although margins that are irregular or lobulated are suspicious for malignancy,
ill-defined margins have not been statistically associated with malignant
nodules and are quite common in benign hyperplastic nodules.
ECHOGENIC FOCI
Echogenic foci are defined as focal areas of significantly increased
echogenicity, which can vary in shape and size, within a nodule. They can be
found in isolation or in combination with artifacts related to acoustic
shadowing.Punctate echogenic foci – These are defined as small echogenic spots
without acoustic shadowing (Figure
14).
Figure 14
Image of a solid nodule, showing punctate echogenic foci. The nodule
pictured was solid (2 points), hypoechoic (2 points), and
wider-than-tall (0 points), with undefined margins (0 points) and
punctate echogenic foci (3 points). Therefore, the total score was 7
points and the risk level was classified as TR5.
Image of a solid nodule, showing punctate echogenic foci. The nodule
pictured was solid (2 points), hypoechoic (2 points), and
wider-than-tall (0 points), with undefined margins (0 points) and
punctate echogenic foci (3 points). Therefore, the total score was 7
points and the risk level was classified as TR5.Macrocalcifications – These are defined as calcifications that are
large enough to generate acoustic shadowing and can be irregular in shape (Figure 15).
Figure 15
Image of a nodule with macrocalcification. Note the intense acoustic
shadowing. The features of (scores for) this nodule were as follows:
solid (2 points); isoechoic (1 point); wider-than-tall (0 points);
smooth margins (0 points); and macrocalcification (1 point).
Therefore, the total score was 4 points and the risk level was
classified as TR4.
Image of a nodule with macrocalcification. Note the intense acoustic
shadowing. The features of (scores for) this nodule were as follows:
solid (2 points); isoechoic (1 point); wider-than-tall (0 points);
smooth margins (0 points); and macrocalcification (1 point).
Therefore, the total score was 4 points and the risk level was
classified as TR4.Peripheral (rim) calcifications – These are defined as
calcifications that occupy the periphery of the nodule and can be continuous or
discontinuous (Figures 16 and 17). They usually produce acoustic shadowing
that obscures the central content of the nodule.
Figure 16
Image of a nodule with peripheral echogenic foci corresponding to
calcifications. The nodule pictured was solid (2 points), hypoechoic
(2 points), and wider-than-tall (0 points), with well-defined
margins (0 points) and peripheral calcifications (2 points).
Therefore, the total score was 6 points and the risk level was
classified as TR4.
Figure 17
Image of a nodule with peripheral calcifications and acoustic
shadowing that obscures its central content. According to the ACR
TI-RADS, when the internal characteristics of a nodule cannot be
determined because of acoustic shadowing, it is prudent to assume
that it is solid and to assign it 2 points for composition, as well
as 1 point for echogenicity. In this case, the nodule was assigned 2
points for being of indeterminate composition, 1 point for being of
indeterminate echogenicity, 0 points for being wider-than-tall, 2
points for having lobulated margins, and 2 points for having
peripheral calcifications. Therefore, the total score was 7 points
and the risk level was classified as TR5.
Image of a nodule with peripheral echogenic foci corresponding to
calcifications. The nodule pictured was solid (2 points), hypoechoic
(2 points), and wider-than-tall (0 points), with well-defined
margins (0 points) and peripheral calcifications (2 points).
Therefore, the total score was 6 points and the risk level was
classified as TR4.Image of a nodule with peripheral calcifications and acoustic
shadowing that obscures its central content. According to the ACR
TI-RADS, when the internal characteristics of a nodule cannot be
determined because of acoustic shadowing, it is prudent to assume
that it is solid and to assign it 2 points for composition, as well
as 1 point for echogenicity. In this case, the nodule was assigned 2
points for being of indeterminate composition, 1 point for being of
indeterminate echogenicity, 0 points for being wider-than-tall, 2
points for having lobulated margins, and 2 points for having
peripheral calcifications. Therefore, the total score was 7 points
and the risk level was classified as TR5.
PRACTICAL EXAMPLES
Here, we provide examples of the practical application of the ACR TI-RADS (Figures 18192021). The captions detail the items evaluated and show the
scores in parentheses.
Figure 18
Image of a nodule that was solid (2 points), isoechoic (1 point), and
wider-than-tall (0 points), with smooth margins (0 points) and
without echogenic foci or acoustic shadowing artifacts (0 points).
Therefore, the total score was 3 points and the risk level was
classified as TR3.
Figure 19
Image of a nodule that was solid (2 points), markedly hypoechoic (3
points), and wider-than-tall (0 points), with smooth margins (0
points) and without echogenic foci or acoustic shadowing artifacts
(0 points). Therefore, the total score was 5 points and the risk
level was classified as TR4.
Figure 20
Image of a mixed solid-cystic nodule (1 point) that was isoechoic (1
point), was wider-than-tall (0 points), and extended beyond the
anterior limit of the thyroid gland (3 points), without echogenic
foci or acoustic shadowing artifacts (0 points). Therefore, the
total score was 5 points and the risk level was classified as
TR4.
Figure 21
Image of a nodule that was solid (2 points), hypoechoic (2 points),
and taller-than-wide (3 points), with undefined margins (0 points)
and without acoustic shadowing artifacts or echogenic foci (0
points). Therefore, the total score was 7 points and the risk level
was classified as TR5.
Image of a nodule that was solid (2 points), isoechoic (1 point), and
wider-than-tall (0 points), with smooth margins (0 points) and
without echogenic foci or acoustic shadowing artifacts (0 points).
Therefore, the total score was 3 points and the risk level was
classified as TR3.Image of a nodule that was solid (2 points), markedly hypoechoic (3
points), and wider-than-tall (0 points), with smooth margins (0
points) and without echogenic foci or acoustic shadowing artifacts
(0 points). Therefore, the total score was 5 points and the risk
level was classified as TR4.Image of a mixed solid-cystic nodule (1 point) that was isoechoic (1
point), was wider-than-tall (0 points), and extended beyond the
anterior limit of the thyroid gland (3 points), without echogenic
foci or acoustic shadowing artifacts (0 points). Therefore, the
total score was 5 points and the risk level was classified as
TR4.Image of a nodule that was solid (2 points), hypoechoic (2 points),
and taller-than-wide (3 points), with undefined margins (0 points)
and without acoustic shadowing artifacts or echogenic foci (0
points). Therefore, the total score was 7 points and the risk level
was classified as TR5.
DISCUSSION
Ultrasound is the main imaging method for evaluating thyroid nodules, and its wide
availability has allowed such nodules to be detected at increasingly higher
rates[(5)]. Therefore,
various risk-stratification models have been developed, each with its own set of
recommendations, which has created confusion among medical professionals. The ACR
TI-RADS was developed with the objective of standardizing the description of and
approaches to thyroid nodules, its practical form making it highly reproducible.The application of the ACR TI-RADS has limitations. First, the use of a point-based
system limits the assessment of scored items and does not take into account
variables that may have different implications, such as the appearance of the solid
component of a solid-cystic nodule; certain aspects of that appearance are known to
be associated with malignancy but are not scored in the ACR TI-RADS([6],[7]). The system also has some pitfalls, which can erroneously
increase the risk level and indicate biopsies unnecessarily. For example, the tiny
punctate hyperechoic foci that represent the standard pattern for the normal
parenchyma can be misinterpreted as echogenic foci[(4)]. In addition, the ACR TI-RADS is of limited
utility in the evaluation of thyroid glands with multiple nodules, such as
multinodular goiters, in which the gland is supplanted by multiple confluent nodules
of similar appearance. Although malignancy cannot be definitively excluded under
these conditions, it would be impracticable to biopsy each of these nodules.
Therefore, the use of the ACR TI-RADS risk-stratification model is not practical in
that scenario[(4)].Despite its limitations, the ACR TI-RADS has a place in clinical practice, although
it must be well understood in order to be used effectively. It provides a
standardized lexicon and facilitates the appropriate management of all thyroid
nodules, making it possible to avoid unnecessary diagnostic procedures, thus
reducing patient discomfort and health care costs([6],[7]).
Authors: Edward G Grant; Franklin N Tessler; Jenny K Hoang; Jill E Langer; Michael D Beland; Lincoln L Berland; John J Cronan; Terry S Desser; Mary C Frates; Ulrike M Hamper; William D Middleton; Carl C Reading; Leslie M Scoutt; A Thomas Stavros; Sharlene A Teefey Journal: J Am Coll Radiol Date: 2015-09-26 Impact factor: 5.532
Authors: Franklin N Tessler; William D Middleton; Edward G Grant; Jenny K Hoang; Lincoln L Berland; Sharlene A Teefey; John J Cronan; Michael D Beland; Terry S Desser; Mary C Frates; Lynwood W Hammers; Ulrike M Hamper; Jill E Langer; Carl C Reading; Leslie M Scoutt; A Thomas Stavros Journal: J Am Coll Radiol Date: 2017-04-02 Impact factor: 5.532
Authors: Il Seong Nam-Goong; Ha Young Kim; Gyungyub Gong; Ho Kyu Lee; Suck Joon Hong; Won Bae Kim; Young Kee Shong Journal: Clin Endocrinol (Oxf) Date: 2004-01 Impact factor: 3.478